You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Pemetrexed

Showing 26 - 50 of 1,179
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Emulation of KEYNOTE-189 Trial Using Electronic Health Records

Active, not recruiting
  • Non-small Cell Lung Cancer
  • Metastatic Lung Cancer
  • Boston, Massachusetts
    Aetion
Jun 14, 2023

NSCLC, Mesothelioma, Bladder Cancer Trial in Augusta (Bosutinib, Pemetrexed)

Completed
  • Carcinoma, Non-Small-Cell Lung
  • +7 more
  • Augusta, Georgia
    Augusta University Georgia Cancer Center
Jun 10, 2022

NSCLC Trial in Xi'an (Furmonertinib+cisplating/pemetrexed)

Recruiting
  • Non-small Cell Lung Cancer
  • Xi'an, Shannxi, China
    Tangdu Hospital
Jun 20, 2022

Non-squamous Non-small-cell Lung Cancer, Brain Metastases Trial in Guangzhou (Camrelizumab, Pemetrexed, Carboplatin)

Active, not recruiting
  • Non-squamous Non-small-cell Lung Cancer
  • Brain Metastases
  • Guangzhou, Guangzhou, China
    Li-Kun Chen
Nov 13, 2022

Non Squamous Non Small Cell Lung Cancer Trial in Korea, Republic of (Camrelizumab (SHR-1210), Pemetrexed, and Carboplatin)

Not yet recruiting
  • Non Squamous Non Small Cell Lung Cancer
  • Camrelizumab (SHR-1210), Pemetrexed, and Carboplatin
  • Anam, Korea, Republic of
  • +7 more
May 1, 2023

CNS Lymphoma Trial in Zhengzhou (ICP-022, Pemetrexed)

Recruiting
  • Central Nervous System Lymphoma
  • Zhengzhou, Henan, China
    Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
Jan 28, 2022

Non Small Cell Lung Cancer, Mesothelioma Trial in Netherlands (Pemetrexed)

Terminated
  • Non Small Cell Lung Cancer
  • Mesothelioma
  • Pemetrexed
  • 's-Hertogenbosch, Netherlands
  • +4 more
May 9, 2022

NSCLC Trial (HS-10241+ Almonertinib, Pemetrexed + Cisplatin /Carboplatin)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • HS-10241+ Almonertinib
  • Pemetrexed + Cisplatin /Carboplatin
  • (no location specified)
Oct 29, 2023

Advanced Lung Non-Small Cell Carcinoma, Non-Small Cell Carcinoma of Lung, TNM Stage 4 Trial in Boston (Granulocyte-Macrophage

Recruiting
  • Advanced Lung Non-Small Cell Carcinoma
  • Non-Small Cell Carcinoma of Lung, TNM Stage 4
  • Granulocyte-Macrophage Colony-Stimulating Factor
  • +4 more
  • Boston, Massachusetts
    Tufts Medical Center
Oct 3, 2022

Non-Squamous NSCLC Trial in Shanghai (Sintilimab, IBI305, Pemetrexed)

Recruiting
  • Non-Squamous Non-Small Cell Lung Cancer
  • Shanghai, Shanghai, China
    Shanghai Chest Hospital
Sep 22, 2022

Non-Squamous NSCLC Trial in Guangzhou (AK112 Injection, Placebo Injection)

Recruiting
  • Non-Squamous Non-small Cell Lung Cancer
  • AK112 Injection
  • Placebo Injection
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
May 23, 2022

Non Small Cell Lung Cancer, Mesothelioma Trial in Netherlands (Pemetrexed)

Completed
  • Non Small Cell Lung Cancer
  • Mesothelioma
  • Pemetrexed
  • 's-Hertogenbosch, Netherlands
  • +4 more
May 9, 2022

Glioma, Brain Metastases Trial in Shanghai (Autologous progenitor expansion -T, pemetrexed)

Recruiting
  • Glioma
  • Brain Metastases
  • Autologous progenitor expansion -T
  • pemetrexed
  • Shanghai, Shanghai, China
    Fudan University Pudong Medical Center
Jul 12, 2022

NSCLC Trial in Gyeonggi-do, Incheon, Seoul (Lazertinib, Pemetrexed, Carboplatin)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Gyeonggi-do, Korea, Republic of
  • +5 more
Jul 25, 2022

Non-Small-Cell Lung Carcinoma Trial in Japan (biological, drug, dietary supplement)

Active, not recruiting
Has Results
  • Non-Small-Cell Lung Carcinoma
  • Pembrolizumab 200 mg
  • +7 more
  • Nagoya, Aichi, Japan
  • +9 more
Jan 23, 2023

Biliary Tract Cancer Trial in Seoul (Pemetrexed 500 MG, Erlotinib)

Recruiting
  • Biliary Tract Cancer
  • Seoul, Korea, Republic of
  • +1 more
Jun 13, 2022

NSCLC Trial (Bemcentinib, Pembrolizumab, Pemetrexed)

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • (no location specified)
Jul 19, 2022

NSCLC Trial in Chongqing (Aumonertinib 165mg orally once daily and intrathecal chemo with pemetrexed)

Recruiting
  • Non-small Cell Lung Cancer
  • Aumonertinib 165mg orally once daily and intrathecal chemotherapy with pemetrexed
  • Chongqing, China
    chongqing University Three Gorges Hospital
Apr 11, 2023

Carcinoma,Non-Small-Cell Lung Trial in Guangzhou (cisplatin and pemetrexed, nedaplatin+pemetrexed)

Recruiting
  • Carcinoma，Non-Small-Cell Lung
  • Guangzhou, Guangdong, China
    Sun Yat-sen University of cancer center
Feb 8, 2022

Non Small Cell Lung Cancer Trial in Tianjin (Osimertinib, Bevacizumab Biosimilar IBI305, Carboplatin)

Recruiting
  • Non Small Cell Lung Cancer
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute and Hospital
Aug 18, 2022

Lung Cancer Trial in Nashville (Pemetrexed, Gemcitabine)

Completed
Has Results
  • Lung Cancer
  • Nashville, Tennessee
    Tennessee Oncology
Feb 21, 2022

Combining Genomics and Imageomics to Predict Sensitivity of

Not yet recruiting
  • Sensitivity
  • Neoadjuvant pemetrexed and cisplatin chemotherapy
  • (no location specified)
Jan 5, 2022

NSCLC Metastatic Trial in Salt Lake City (Durvalumab, Pemetrexed, Carboplatin)

Recruiting
  • Non-Small Cell Lung Cancer Metastatic
  • Salt Lake City, Utah
    Huntsman Cancer Institute at University of Utah
Mar 1, 2022

NSCLC Trial in Tianjin (Tislelizumab, Pemetrexed, Bevacizumab)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute and Hospital
Jul 11, 2022

MPM Trial in Changchun (PM8002, Pemetrexed, Cisplatin)

Recruiting
  • MPM
  • Changchun, China
    Jilin Provincial Tumor Hospital
Jun 25, 2023